Review of rationale for neurofeedback application in adolescent substance abusers with comorbid disruptive behavioral disorders

Journal of Neurotherapy

Volumn 15, Issue 3, 2011, Pages 232-261

  Sokhadze, Estate ^a   Stewart, Christopher M ^a   Tasman, Allan ^a   Daniels, Robert ^b   Trudeau, David ^c  

^a University of Louisville School of Medicine   (United States)

^b Louisville Adolescent Network for Substance Abuse Treatment   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; OPIATE;

ALCOHOL ABUSE; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; AUTOREGULATION; COGNITIVE THERAPY; COMORBIDITY; CONDUCT DISORDER; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; DRUG DEPENDENCE; DRUG MISUSE; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERACTIVITY; IMPULSIVENESS; NEUROFEEDBACK; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; OPPOSITIONAL DEFIANT DISORDER; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE;

EID: 80052206458     PISSN: 10874208     EISSN: 1530017X     Source Type: Journal    
DOI: 10.1080/10874208.2011.595298     Document Type: Article

References (238)

1. Aguilar de Arcos, F., Verdejo-Garcia, A. J., Peralta-Ramirez, M. I., Sanchez-Barrera, M., & Perez-Garcia, M. (2005). Experience of emotions in substance abusers exposed to images containing neutral, positive, and negative affective stimuli. Drug and Alcohol Dependence, 78, 159-167.
2. Alper, K. R., Chabot, R. J., Kim, A. H., Prichep, L. S., & John, E. R. (1990). Quantitative EEG correlates of crack cocaine dependence. Psychiatry Research, 35, 95-106.
3. Alper, K. R., Chabot, R. J., Kim, A. H., Prichep, L. S., & John, E. R. (1993). Crack cocaine dependence: Discrimination from major depression using qEEG variables. In K. Mauer (Ed.), Imaging of the brain in psychiatric and related fields (pp. 289-293). Berlin, Germany: Springer-Verlag.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
5. Anderson, J., Williams, S., McGee, R., & Silva, P. (1987). DSM-III disorders in preadolescent children. Archives of General Psychiatry, 44, 69-76.
6. Anderson, K. G., Ramo, D. E., Cummins, K. M., & Brown, S. A. (2010). Alcohol and drug involvement after adolescent treatment and functioning during emerging adulthood. Drug and Alcohol Dependence, 107, 171-181.
7. Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009). Efficacy of neurofeedback treatment in ADHD: The effects of inattention, impulsivity and hyperactivity: A meta-analysis. Clinical EEG and Neuroscience, 40, 180-189.
8. Aron, A. R., & Poldrack, R. A. (2005). The cognitive neuroscience of response inhibition: Relevance for genetic research in attentiondeficit/ hyperactivity disorder. Biological Psychiatry, 57, 1285-1292.
9. Banaschewski, T., & Brandeis, D. (2007). Annotation: What electrical brain activity tells us about brain function that other techniques cannot tell us-a child psychiatric perspective. Journal of Child Psychology and Psychiatry, 48, 415-435.
10. Banaschewski, T., Brandeis, D., Heinrich, H., Albrecht, B., Brunner, E., & Rothenberger, A. (2003). Association of ADHD and conduct disorder-Brain electrical evidence for the existence of a distinct subtype. Journal of Child Psychology and Psychiatry, 44, 356-376.
11. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65-94.
12. Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. Journal of American Academy of Child and Adolescent Psychiatry, 29, 546-557.
13. Barry, R. J., Clarke, A. R., & Johnstone, S. J. (2003a). A review of electrophysiology in attention-deficit/hyperactivity disorder: I Qualitative and quantitative electroencephalography. Clinical Neurophysiology, 114, 171-183.
14. Barry, R. J., Clarke, A. R., & Johnstone, S. J. (2003b). A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clinical Neurophysiology, 114, 184-198.
15. Barry, R. J., Clarke, A. R., McCarthy, R., & Selikowitz, M. (2007). EEG coherence in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Clinical Neurophysiology, 118, 356-362.
16. Basar, E., & Güntekin, B. (2008). A review of brain oscillations in cognitive disorders and the role of neurotransmitters. Brain Research, 1235, 172-193.
17. Bauer, L. O. (1997). Frontal P300 decrement, childhood conduct disorder, family history, and predisposition of relapse among abstinent cocaine abusers. Drug Alcohol Dependence, 44, 1-10.
18. Bauer, L. O., & Hesselbrock, V. M. (1993). EEG autonomic and subjective correlates for alcoholism. Journal of Studies on Alcohol, 54, 577-589.
19. Bauer, L. O., & Hesselbrock, V. M. (1999). Subtypes of family history and conduct disorder: Effects on P300 during the Stroop test. Neuropsychopharmacology, 21(1), 51-62.
20. Bauer, L. O., & Hesselbrock, V. M. (2001). CSD/BEM localization of P300 sources in adolescents "at risk": Evidence of frontal cortex dysfunction in conduct disorder. Biological Psychiatry, 50, 600-608.
21. Bauer, L. O., & Hesselbrock, V. M. (2002). Lateral asymmetries in the frontal brain: Effects of depression and a family history of alcoholism in female adolescents. Alcoholism Clinical and Experimental Research, 26, 1662-1668.
22. Bauer, L. O., O'Connor, S., & Hesselbrock, V. M. (1994). Frontal P300 decrements in antisocial personality disorder. Alcohol Clinical & Experimental Research, 18, 1300-1305.
23. Becker, S. J., & Curry, J. F. (2008). Outpatient interventions for adolescent substance abuse: A quality of evidence review. Journal of Consulting and Clinical Psychology, 76, 531-543.
24. Begleiter, H., & Porjesz, B. (1995). Neurophysiological phenotypic factors in the development of alcoholism. In H. Begleiter & B. Kissen (Eds.), The genetics of alcoholism (pp. 269-293). New York, NY: Oxford University Press.
25. Begleiter, H., Porjesz, B., Bihari, B., & Kissin, B. (1984). Event related brain potentials in boys at risk for alcoholism. Science, 225, 1493-1496.
26. Biederman, J. (2003). Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: Findings from a longitudinal follow-up of youths with and without ADHD. Journal of Clinical Psychiatry, 64(11), 3-8.
27. Biederman, J., Spencer, T. J., Newcorn, J. H., Gao, H., Milton, D. R., Feldman, P. D., & Witte, M. M. (2006). Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: A meta-analysis of controlled clinical trial data. Psychopharmacology, 190, 31-41.
28. Biederman, J., Wilens, T., Mick, E., Faraone, S. V., Weber, W., Curtis, S.,... Soriano, J. (1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal American Academy Child Adolescent Psychiatry, 36, 21-29.
29. Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J., & Farone, S. V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652-1658.
30. Bird, H., Gould, M., & Staghezza, B. (1993). Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. Journal of American Academy of Child and Adolescent Psychiatry, 32, 361-368.
31. Bodenhamer-Davis, E., & Callaway, T. (2004). Extended follow-up of Peniston Protocol results with chemical dependency. Journal of Neurotherapy, 8, 135.
32. Brady, K. T. (1997). Posttraumatic stress disorder and comorbidity: Recognizing the many faces of PTSD. Journal of Clinical Psychiatry, 58(Suppl. 9), 12-15.
33. Brandeis, D., Banaschewski, T., Baving, L., Georgiewa, P., Blanz, B., & Warnke, A. (2002). Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children. Journal of American Academy of Child and Adolescent Psychiatry, 41, 990-998.
34. Brannigan, R., Schackman, B. R., Falco, M., & Millman, R. B. (2004). The quality of highly regarded adolescent substance abuse treatment programs. Archives of Pediatrics & Adolescent Medicine, 158, 904-909.
35. Bremner, J. D., Southwick, S. M., Darnell, A., & Charney, D. S. (1996). Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse. American Journal of Psychiatry, 153, 369-375.
36. Brown, P. J., Recupero, P. R., & Stout, R. (1995). PTSD-substance abuse comorbidity and treatment utilization. Addictive Behavior, 20, 251-254.
37. Brownell, M. D., & Yogendran, M. S. (2001). Attention-deficit hyperactivity disorder in Manitoba children: Medical diagnosis and psychostimulant treatment rates. Canadian Journal Psychiatry, 46, 264-272.
38. Burgess, G. C., Depue, B. E., Ruzic, L., Willcutt, E. G., Du, Y. P., & Banich, M. (2010). Attention control activation relates to working memory in attention-deficit/ hyperactivity disorder. Biological Psychiatry, 67, 632-640.
39. Burke, J. D., Waldman, I., & Lahey, B. B. (2010). Predictive validity of childhood oppositional defiant disorder and conduct disorder: Implications for the DSM-V. Journal of Abnormal Psychology, 119, 739-751.
40. Burkett, S. V., Cummins, J. M., Dickson, R., & Skolnick, M. H. (2005). An open clinical trial utilizing real-time EEG operant conditioning as an adjunctive therapy in the treatment of crack cocaine dependence. Journal of Neurotherapy, 9(2), 27-47.
41. Cadoret, R. J., Troughton, E., & O'Gorman, W. (1987). Genetic and environmental factors in alcohol abuse and antisocial personality disorder. Journal Studies on Alcohol, 48(1), 1-8.
42. Carlson, S. R., Iacono, W. G., & McGue, M. (2002). P300 amplitude in adolescent twins discordant and concordant for alcohol use disorder. Biological Psychology, 61, 203-227.
43. Carroll, K. M., & Rounsaville, B. J. (1993). History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry, 34, 75-82.
44. Castaneda, R., Levy, R., Hardy, M., & Trujillo, M. (2000). Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatric Services, 51, 169-171.
45. Chabot, R. J., diMichele, F., & Prichep, L. (2005). The role of quantitative electroencephalography in child and adolescent psychiatric disorders. Child and Adolescent Psychiatric Clinics of North America, 14, 21-53.
46. Chabot, R. J., & Serfontein, G. (1996). Quantitative EEG profiles of children with Attention Deficit Disorder. Biological Psychiatry, 40, 951-963.
47. Chan, Y.-F., Dennis, M. L., & Funk, R. R. (2008). Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment, 34, 14-24.
48. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (1998). EEG analysis in attention-deficit/ hyperactivity disorder: A comparative study of two subtypes. Psychiatry Research, 81, 19-29.
49. Clarke, A., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001). EEG-defined subtypes of children with attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 112, 2098-2105.
50. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2002). Children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: An EEG analysis. Psychiatry Research, 111, 181-190.
51. Clarke, A. R., Barry, R. J., McCarthy, R., Selikowitz, M., & Brown, C. R. (2002). EEG evidence for a new conceptualization of attention deficit hyperactivity disorder. Clinical Neurophysiology, 113, 1036-1044.
52. Coger, R. W., Dymond, A. M., & Serafetinides, E. A. (1978). EEG signs of brain impairment in alcoholism. Biological Psychiatry, 13, 729-739.
53. Coger, R. W., Dymond, A. M., & Serafetinides, E. A. (1979). Electroencephalographic similarities between chronic alcoholics and chronic non-paranoid schizophrenics. Archives of General Psychiatry, 36, 91-94.
54. Cornwell, A., Roemer, R. A., Jackson, P., & Dewart, D. (1994). Paroxysmal-like EEG abnormalities associated with chronic polydrug abuse. Biological Psychiatry, 35, 692-693.
55. Corr, P. J. (2002). J. A. Gray's reinforcement sensitivity theory and frustrative nonreward: A theoretical note on expectancies in reactions to rewarding stimuli. Personality Individual Differences, 32, 1247-1253.
56. Couwenbergh, C., Brink, W., Zwart, K., Vreugdenhil, C., Wijngaarden-Cremers, P., & Gaag, R. J. (2006). Comorbid psychopathology in adolescents and young adults treated for substance use disorders. European Child and Adolescent Psychiatry, 15, 319-328.
57. Crits-Christoph, P., Siqueland, L., Blaine, J., Frank, A., Luborsky, L., Onken, L. S.,... Beck, A. T. (1997). The National Institute on Drug Abuse Collaborative Cocaine Treatment Study: Rationale and methods. Archives of General Psychiatry, 54, 721-726.
58. Crits-Christoph, P., Siqueland, L., Blaine, J., Frank, A., Luborsky, L., Onken, L. S.,... Beck, A. T. (1999). Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Archives of General Psychiatry, 56, 493-450.
59. Cyders, M. A., & Smith, G. T. (2008). Emotionbased dispositions to rash action: Positive and negative urgency. Psychological Bulletin, 134, 807-828.
60. Daniels, R., & Laundenwich, S. (2007, October). Louisville Adolescent Network for Substance Abuse Treatment (Report to the Board). Louisville, KY.
61. Davids, E., von Bunau, U., Specka, M., Fischer, B., Scherbaum, N., & Gastpar, M. (2005). History of attention-deficit hyperactivity disorder symptoms and opioid dependence: A controlled study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 291-296.
62. Deas, D., & Thomas, S. E. (2001). An overview of controlled studies of adolescent substance abuse treatment. American Journal on Addictions, 10, 178-189.
63. De Boo, G. M., & Prins, P. J. M. (2007). Social incompetence in children with ADHD: Possible moderators and mediators in social-skills training. Clinical Psychology Review, 27, 78-97.
64. Dennis, M. L., White, M. K., Titus, J. C., & Unsicker, J. I. (2006). Global Appraisal of Individual Needs (GAIN): Administration guide and related measures (Version 5). Bloomington, IL: Chestnut Health Systems.
65. Doehnert, M., Brandeis, D., Imhof, K., Drechsler, R., & Steinhausen, H. C. (2010). Mapping attention-deficit/hyperactivity disorder from childhood to adolescence-No neurophysiologic evidence for a developmental lag of attention but some inhibition. Biological Psychiatry, 67, 608-616.
66. Downey, K. K., Stelson, F.W., Pomerleau, O. F., & Giordani, B. (1997). Adult attention deficit hyperactivity disorder: Psychological test profiles in a clinical population. Journal of Nervous and Mental Diseases, 185(1), 32-38.
67. Doyle, A. E., Willcutt, E. G., Seidman, L. J., Biederman, J., Chouinard, V. A., Silva, J., & Faraone, S. V. (2005). Attention-deficit/ hyperactivity disorder endophenotypes. Biological Psychiatry, 57, 1324-1335.
68. Du, J., Li, J., Wang, Y., Jiang, Q., Livesley, W. J., Jang, K. L., Wang, K., & Wang, W. (2006). Event-related potentials in adolescents with combined ADHD and CD disorder: A single stimulus paradigm. Brain and Cognition, 60(1), 70-75.
69. Durston, S., & Konrad, K. (2007). Integrating genetic, psychopharmacological and neuroimaging studies: A converging methods approach to understanding the neurobiology of ADHD. Developmental Review, 27, 374-395.
70. Ehlers, C. L., & Criado J. R. (2010). Adolescent ethanol exposure: Does it produce long-lasting electrophysiological effects? Alcohol, 44, 27-37.
71. Etheridge, R. M., Smith, J. C., Rounds-Bryant, J. L., & Hubbard, R. L. (2001). Drug abuse treatment and comprehensive services for adolescents. Journal of Adolescent Research, 16, 563-589.
72. Everitt, B. J., Belin, D., Economodou, D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. (2008). Neural mechanisms underlying the vulnerability to develop compulsive drugseeking habits and addiction. Philosophical Transactions Royal Society London: Biological Sciences, 363, 3125-3135.
73. Falkenstein, M., Hoormann, J., Christ, S., & Hohnsbein, J. (2000). ERP components on reaction errors and their functional significance: A tutorial. Biological Psychology, 51, 87-107.
74. Falkenstein, M., Hoormann, J., & Hohnsbein, J. (1999). ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychologica, 101, 267-291.
75. Finkelberg, A., Sokhadze, E., Lopatin, A., Shubina, O., Kokorina, N., Skok, A., & Shtark, M. (1996). The application of alphatheta EEG biofeedback training for psychological improvement in the process of rehabilitation of the patients with pathological addictions. Biofeedback and Self-Regulation, 21, 364.
76. Fox, D. J., Tharp, D. F., & Fox, L. C. (2005). Neurofeedback: An alternative and efficacious treatment for attention deficit hyperactivity disorder. Applied Psychophysiology & Biofeedback, 30, 365-373.
77. Franken, I. H. A., Stam, C. J., Hendriks, V. M., & van den Brink, W. (2004). Electroencephalographic power and coherence analysis suggest altered brain function in abstinent male heroin-dependent patients. Neuropsychobiology, 49, 105-110.
78. Franzer, J. (2005). The status of health service research on adjudicated drug-abusing juveniles: Selected findings and remaining questions. Substance Use & Misuse, 40, 887-911.
79. Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., & Kaiser, J. (2003). Neurofeedback treatment for attention-deficit/ hyperactivity disorder in children: A comparison with methylphenidate. Applied Psychophysiology and Biofeedback, 28(1), 1-12.
80. Fukunishi, I. (1996). Alexithymia in substance abuse: Relationship to depression. Psychology Reports, 78, 641-642.
81. Gabrielli, W. F., Mednick, S. A., & Volavka, J. (1982). EEGs in children of alcoholic fathers. Psychophysiology, 19, 404-407.
82. Gehring, W. J., & Knight, R. T. (2000). Prefrontalcingulate interactions in action monitoring. Nature Neuroscience, 3, 516-520.
83. Gerra, G., Baldaro, B., Zaimovic, A., Moi, G., Bussandri, M., Raggi, M. A., & Brambilla, F. (2003). Neuroendocrine responses to experimentally-induced emotions among abstinent opioid-dependent subjects. Drug & Alcohol Dependence, 71, 25-35.
84. Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P.,... Heinrich, H. (2009). Distinct EEG effects related to neurofeedback training in children with ADHD: A randomized controlled trial. International Journal of Psychophysiology, 74, 149-157.
85. Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P.,... Heinrich, H. (2010). Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial. European Child and Adolescent Psychiatry, 19, 715-724.
86. Gevensleben, H., Holl, B., Albrecht, B., Vogel, C., Schlamp, D., Kratz, O.,... Heinrich, H. (2009). Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. Child Psychology & Psychiatry, 50, 780-789.
87. Gittelman, R., Mannuzza, S., Shenker, R., & Bonagura, N. (1985). Hyperactive boys almost grown up. Archives of General Psychiatry, 42, 937-947.
88. Goldstein, R. Z., & Volkow, N. D. (2002). Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry, 159, 1642-1652.
89. Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors, 29, 1439-1464.
90. Graetz, B. W., Sawyer, M. G., Hazell, P. L., Arney, F., & Baghurst, P. (2001). Validity of DSM-IV ADHD subtypes in a nationally representative sample of Australian children and adolescents. Journal of American Academy Child Adolescent Psychiatry, 40, 1410-1417.
91. Habeych, M. E., Charles, P. J., Sclabassi, R. J., Kirisci, L., & Tarter, R. E. (2005). Direct and mediated associations between P300 amplitude in childhood and substance use disorders outcome in young adulthood. Biological Psychiatry, 57, 76-82.
92. Hada, M., Porjesz, B., Begleiter, H., & Polich, J. (2000). Auditory P3a assessment of male alcoholics. Biological Psychiatry, 48, 276-286.
93. Heinrich, H., Gevensleben, H., & Strehl, U. (2007). Neurofeedback-Train your brain to train behavior. Journal of Child Psychology and Psychiatry, 48, 3-16.
94. Hermens, D. F., Kohn, M. R., Clarke, S. D., Gordon, E., & Williams, L. M. (2005). Sex differences in adolescent ADHD: Findings from concurrent EEG and EDA. Clinical Neurophysiology, 116, 1455-1463.
95. Herning, R. I., Better, W., & Cadet, J. L. (2008). EEG of chronic marijuana users during abstinence: Relationship to years of marijuana use, cerebral blood flow and thyroid function. Clinical Neurophysiology, 119, 321-331.
96. Herrmann, C. S., & Demiralp, T. (2005). Human EEG gamma oscillations in neuropsychiatric disorders. Clinical Neurophysiology, 116, 2719-2733.
97. Hestler, R., Dixon, V., & Garavan, H. (2006). A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug and Alcohol Dependence, 81, 251-257.
98. Hill, S. Y., Yuan, H., & Locke, J. (1999). Path analysis of P300 amplitude from families at high and low risk for developing alcoholism. Biological Psychiatry, 45, 346-359.
99. Hoedlmoser, K., Pecherstorfer, T., Gruber, G., Anderer, P., Doppelmayr, M., Klimesch, W., & Schabus, M. (2008). Instrumental conditioning of human sensorimotor rhythm (12-15 Hz) and its impact on sleep as well as declarative learning. Sleep, 31, 1401-1408.
100. Holroyd, C. B., & Coles, M. G. (2002). The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity. Psychology Review, 109, 679-709.
101. Holtmann, M., & Stadler, C. (2006). Electroencephalographic biofeedback for the treatment of attention-deficit hyperactivity disorder in childhood and adolescence. Expert Review of Neurotherapeutics, 6, 533-540.
102. Horner, B. R., & Scheibe, K. E. (1997). Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. Journal of the American Academy of Child and Adolescent Psychiatry, 36(1), 30-36.
103. Horrell, T., Sokhadze, E., Stewart, C., El-Baz, A., & Tasman, A. (2010). Evoked and induced gamma EEG response to drug cues in cocaine addicts after neurofeedback treatment. Journal of Neurotherapy, 14(3), 195-216.
104. Hser, Y.-I., Grella, C. E., Hubbard, R. L., Hsieh, S.-C., Fletcher, B. W., Brown, B. S., & Anglin, M. D. (2001). An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry, 58, 689-695.
105. Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503-508.
106. Hsu, L., Wisner, K., Richey, E., & Goldstein, C. (1985). Is juvenile delinquency related to abnormal EEG? A study of EEG abnormalities in juvenile delinquents and adolescent psychiatric inpatients. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 310-315.
107. Iacono, W. G., Carlson, S. R., Malone, S. M., & McGue, M. (2002). P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys. Archives of General Psychiatry, 59, 750-757.
108. Jensen, P., Martin, D., & Cantwell, D. (1997). Comorbidity in ADHD: Implications for research, practice, and DSM-V. Journal of American Academy of Child and Adolescent Psychiatry, 36, 1065-1079.
109. Kalbag, A. S., & Levin, F. R. (2005). Adult ADHD and substance abuse: Diagnostic and treatment issues. Substance Use and Misuse, 40, 1955-1981.
110. Kalechstein, A. D., Newton, T. F., Longshore, D., Anglin, M. D., van Gorp, W. G., & Gawin, F. H. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 480-484.
111. Kamarajan, C., Porjesz, B., Jones, K. A., Choi, K., Chorlian, D. B., Padmanabhapillai, A.,... Begleiter, H. (2004). The role of brain oscillations as functional correlates of cognitive systems: A study of frontal inhibitory control in alcoholism. International Journal of Psychophysiology, 51, 155-180.
112. Kamarajan, C., Porjesz, B., Jones, K., Chorlian, D., Padmanabhapillai, A., Rangaswamy, M.,... Begleiter, H. (2006). Event-related oscillations in offspring of alcoholics: Neurocognitive disinhibition as a risk for alcoholism. Biological Psychiatry, 59, 625-634.
113. Kazdin, A. E., & Nock, M. K. (2003). Delineating mechanisms of change in child and adolescent therapy: Methodological issues and research recommendations. Journal of Child Psychology and Psychiatry, 44, 1116-1129.
114. Keizer, A. W., Verment, R. S., & Hommel, B. (2010). Enhancing cognitive control through neurofeedback: A role of gamma-band activity in managing episodic retrieval. NeuroImage, 49, 3404-3413.
115. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry, 142, 1259-1264.
116. Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsiderations and recent applications. Harvard Review Psychiatry, 4, 231-244.
117. Kim, M. S., Kim, J. J., & Kwon, J. S. (2001). Frontal P300 decrement and executive dysfunction in adolescents with conduct problems. Child Psychiatry Human Development, 32, 93-106.
118. Kirisci, L., Vanyukov, M., & Tarter, R. (2005). Detection of youth at high risk for substance use disorders: A longitudinal study. Psychology of Addictive Behaviors, 19, 243-252.
119. Knudsen, H. K. (2009). Adolescent-only substance abuse treatment: Availability and adoption of components of quality. Journal of Substance Abuse Treatment, 36, 195-204.
120. Kollins, S. H. (2008). A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co-morbid substance use disorders. Current Medical Research and Opinion, 24, 1345-1357.
121. Konrad, K., Neufang, S., Hanisch, C., Fink, G. R., & Herpertz-Dahlmann, B. (2006). Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study. Biological Psychiatry, 59, 643-665.
122. Koob, G. F. (1999). Stress, corticotropin-releasing factor, and drug addiction. Annals of New York Academy of Sciences, 897, 27-45.
123. Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97-129.
124. Kraemer, H. C., Wilson, G., Fairburn, C. G., & Agras, W. (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry, 59, 877-884.
125. Kropotov, J. D., Grin-Yatsenko, V. A., Ponomarev, V. A., Chutko, L. S., Yakovenko, E. A., & Nikishena, I. S. (2005). ERPs correlates of EEG relative beta training in ADHD children. International Journal of Psychophysiology, 55(1), 23-34.
126. Lahey, B. B., Loeber, R., Quay, H. C., Frick, P. J., & Grimm, J. (1992). Oppositional defiant and conduct disorders: Issues to be resolved for DSM-IV. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 539-546.
127. Lazzaro, I., Gordon, E., Whitmont, S., Plahn, M., Li, W., Clarke, S.,... Meares, R. (1998). Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clinical Electroencephalography, 29, 37-42.
128. Leins, U., Goth, G., Hinterberger, T., Klinger, C., Rumpf, N., & Strehl, U. (2007). Neurofeedback for children with ADHD: A comparison of SCP and Theta/Beta protocols. Applied Psychophysiology & Biofeedback, 32(2), 73-88.
129. Lenz, D., Krauel, K., Flechtner, H. H., Schadow, J., Hinrichs, H., & Herrmann, C. S. (2010). Altered evoked gamma-band responses reveal impaired early visual processing in ADHD children. Neuropsychologia, 48, 1985-1993.
130. Lenz, D., Krauel, K., Schadow, J., Baving, L., Duzel, E., & Herrmann, C. S. (2008). Enhanced gamma-band activity in ADHD patients lacks correlation with memory performance found in healthy children. Brain Research, 1235, 117-132.
131. Levesque, J., Beauregard, M., & Mensour, B. (2006). Effects of neurofeedback training on the neural substrates of selective attention in children with attention-deficit/ hyperactivity disorder: A functional magnetic resonance imaging study. Neuroscience Letters, 394, 216-221.
132. Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007). Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence, 87(1), 20-29.
133. Levin, F., Evans, S., Mcdowell, D., & Kleber, H. (1998). Methylphenidate treatment for cocaine abusers with adult attention-deficit/ hyperactivity disorder: A pilot study. Journal Clinical Psychiatry, 59, 300-305.
134. Levin, F. R., & Kleber, H. D. (1995). Attentiondeficit hyperactivity disorder and substance abuse: Relationships and implications for treatment. Harvard Review of Psychiatry, 2, 246-258.
135. Linden, M., Habib, T., & Radojevic, V. (1996). A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback and Self-Regulation, 21(1), 35-49.
136. Liotti, M., Pliszka, S. R., Higgins, K., Perez, R. III, & Semrud-Clikeman, M. (2010). Evidence for specificity of ERP abnormalities during response inhibition in ADHD children: A comparison with reading disorder children without ADHD. Brain and Cognition, 72, 228-237.
137. Loeber, R., Burke, J.D., Lahey, B. B., Winters, A., & Zera, M. (2000). Oppositional defiant and conduct disorder: A review of the past 10 years. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 1468-1484.
138. Lubar, J. F. (2003). Neurofeedback for the management of attention deficit disorders. In M. S. Schwartz & F. Andrasik (Eds.), Biofeedback: A practitioner's guide, 3rd ed. (pp. 409-437). New York, NY: Guilford.
139. Lubar, J. F. (Ed.). (2004). Quantitative electroencephalographic analysis (QEEG) databases for neurotherapy: Description, validation, and application. Binghamton, NY: Haworth.
140. Mann, C., Lubar, J., Zimmerman, A., Miller, C., & Muenchen, R. (1992). Quantitative analysis of EEG in boys with attention deficit hyperactivity disorder: Controlled study with clinical implications. Pediatric Neurology, 8, 30-36.
141. Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., & LaPadula, M. (1998). Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry, 155, 493-498.
142. Mannuzza, S., Klein, R. G., Bonagura, N., Malloy, P., Giampino, T. L., & Addalli, K. A. (1991). Hyperactive boys almost grown up, V. Replication of psychiatric status. Archives of General Psychiatry, 48, 77-83.
143. Mannuzza, S., Klein, R. G., Konig, P. H., & Giampino, P. L. (1989). Hyperactive boys almost grown up, IV. Criminality and its relationship to psychiatric status. Archives of General Psychiatry, 46, 1073-1079.
144. Mannuzza, S., Klein, R. G., & Moulton, J. L. (2003). Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. Journal of Child Adolescent Psychopharmacology, 13(3), 273-282.
145. Mariani, J. J., & Levin, F. R. (2007). Treatment strategies for co-occurring ADHD and substance use disorders. American Journal Addiction, 16(Suppl. 1), 45-56.
146. Martin, G. (2003). EEG biofeedback with incarcerated adolescent felons. Journal of Neurotherapy, 7(1), 66-67.
147. Mcardle, P., O'Brien, G., & Kolvin, I. (1995). Hyperactivity: Prevalence and relationship with conduct disorder. Journal of Child Psychology and Psychiatry, 36, 279-305.
148. Miller, W., & Rollnick, S. (2002). Motivational interviewing. New York, NY: Guilford. Mirza, K., & Mirza, S. (2008). Adolescent substance misuse. Psychiatry, 7, 357-362.
149. Molina, B. S., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S.,... Houck, P. R. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 484-500.
150. Monastra, V. J. (2003). Clinical applications of electroencephalographic biofeedback. In M. S. Schwartz & F. Andrasik (Eds.), Biofeedback: A practitioner's guide 3rd ed. (pp. 438-463). New York, NY: Guilford.
151. Monastra, V. J., Lubar, J. F., & Linden, M. (2001). The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: Reliability and validity studies. Neuropsychology, 15(1), 136-144.
152. Monastra, V. J., Lynn, S., Linden, M., Lubar, J. F., Gruzelier, J., & LaVaque, T. J. (2005). Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Applied Psychophysiology & Biofeedback, 30, 95-114.
153. Monastra, V. J., Monastra, D. M., & George, S. (2002). The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/ hyperactivity disorder. Applied Psychophysiology and Biofeedback, 27, 231-249.
154. Multimodal Treatment of ADHD (MTA) Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD). Archives of General Psychiatry, 56, 1073-1086.
155. Multimodal Treatment of ADHD (MTA) Cooperative Group. (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/ hyperactivity disorder. Pediatrics, 113, 754-761.
156. Nigg, J. T. (2005). Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: The state of the field and salient challenges for the coming decade. Biological Psychiatry, 57, 1424-1435.
157. O'Brien, C. P., Charney, D. S., Lewis, L., Cornish, J. W., Post, R. M., Woody, G. E.,... Weisner, C. (2004). Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action. Biological Psychiatry, 56, 703-713.
158. O'Connor, S., Bauer, L. O., Tasman, A., & Hesselbrock, V. M. (1994). Reduced P3 amplitudes of ERPs are associated with both a family history of alcoholism and antisocial personality disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 18, 1307-1321.
159. Okazaki, S., Ozaki, H., Maekawa, H., & Futakami, S. (2004). Longitudinal change of ERP during cued continuous performance test in child with attention-deficit/hyperactivity disorder. International Congress Series, 1270, 254-257.
160. Ouimette, P. C., Finney, J. W., & Moos, R. (1999). Two-year posttreatment functioning and coping of substance abuse patients with posttraumatic stress disorder. Psychology of Addictive Behaviors, 13, 105-114.
161. Pardini, D. A., & Fite, P. J. (2010). Symptoms of conduct disorder, oppositional defiant disorder, attention-deficit/hyperactivity disorder, and callous-unemotional traits as unique predictors of psychosocial maladjustment in boys: Advancing an evidence base for DSM-V. Journal of American Academy of Child Adolescent Psychiatry, 49, 1134-1144.
162. Pardini, D. A., Fite, P. J., & Moffitt, T. E. (2010). Building an evidence base for DSM-5 conceptualizations of oppositional defiant disorder and conduct disorder: Introduction to the special section. Journal of Abnormal Psychology, 119, 683-688.
163. Peniston, E. G., & Kulkosky, P. J. (1989). Alpha-Theta brainwave training and beta endorphin levels in alcoholics. Alcoholism Clinical and Experimental Research, 13, 271-279.
164. Peniston, E. G., & Kulkosky, P. G. (1991). Alpha-theta brain wave neurofeedback for Vietnam veterans with combat related post traumatic stress disorder. Medical Psychotherapy, 4, 1-14.
165. Pliszka, S. (1998). Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: An overview. Journal of Clinical Psychiatry, 59(Suppl.), 50-58.
166. Prichep, L. S., Alper, K., Kowalik, S. C., Merkin, H., Tom, M., John, E. R., & Rosenthal, M. S. (1996). Quantitative electroencephalographic characteristics of crack cocaine dependence. Biological Psychiatry, 40, 986-993.
167. Prichep, L. S., Alper, K. R., Sverdlov, L., Kowalik, S. C., John, E. R., Merkin, H.,... Rosenthal, M. S. (2002). Outcome related electrophysiological subtypes of cocaine dependence. Clinical Electroencephalography, 33(1), 8-20.
168. Prichep, L. S., & John, E. R. (1997). Quantitative EEG (QEEG) and psychiatric classification. Biological Psychiatry, 42, 64S.
169. Prinz, R. J. (1998). Conduct disorders. In A. S. Bellack & M. Hersen (Eds.), Comprehensive clinical psychology (pp. 527-538). New York, NY: Elsevier Science.
170. Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change. Applications to addictive behaviors. American Psychologist, 47, 1102-1114.
171. Quirk, D. A. (1995). Composite biofeedback conditioning and dangerous offenders: III. Journal of Neurotherapy, 1, 44-54.
172. Rangaswamy, M., Stimus, A. T., & Begleiter, H. (2005). Alcoholism is a disinhibitory disorder: Neurophysiological evidence from a Go/No-Go task. Biological Psychology, 69, 353-373.
173. Ridderinkhof, K. R., Ullsperger, M., Crone, E. A., & Nieuwenhuis, S. (2004). The role of the medial frontal cortex in cognitive control. Science, 306, 443-447.
174. Ridenour, A., Hall, D. L., & Bost, J. E. (2009). A small sample randomized clinical trial methodology using N-of-1 designs and mixed model analysis. The American Journal of Drug and Alcohol Abuse, 35, 260-266.
175. Riggs, N. R., & Greenberg, M. T. (2009). Neurocognition as a moderator and mediator in adolescent substance misuse prevention. American Journal of Drug and Alcohol Abuse, 35, 209-213.
176. Riggs, P. D., & Jellinek, M. S. (1998). Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 331-332.
177. Robinson, T. E., & Berridge, K. C. (2008). The incentive sensitization theory of addiction: Some current issues. Philosophical transactions Royal Society London: Biological Sciences, 363, 3137-3146.
178. Roemer, R. A., Cornwell, A., Jackson, P., & Dewart, D. (1994). Quantitative EEG measures: Correlations with lifetime exposure to cocaine, alcohol, and marijuana in chronic polydrug. Biological Psychiatry, 35, 624-625.
179. Rossiter, T. R., & LaVaque, T. J. (1995). A comparison of EEG biofeedback and psychostimulants in treating attention deficit/ hyperactivity disorders. Journal of Neurotherapy, 1, 48-59.
180. Rothenberger, A., Banaschewski, T., Heinrich, H., Moll, G. H., Schmidt, M. H, & van Klooster, B. (2000). Comorbidity in ADHD-children: Effects of coexisting conduct disorder or tic disorder on event-related brain potentials in an auditory selective-attention task. European Archive Psychiatry Clinical Neuroscience, 250, 101-110.
181. Satterfield, J. H., Schell, A. M., & Nicholas, T. W. (1984). Preferential neural processing of attended stimuli in attention-deficit hyperactivity disorder and normal boys. Psychophysiology, 31(1), 1-10.
182. Satterfield, J. H., Schell, A. M., Nicholas, T. W., Satterfield, B. T., & Freese, T. E. (1990). Ontogeny of selective attention effects on event-related potentials in attention-deficit hyperactivity disorder and normal boys. Biological Psychiatry, 28, 879-903.
183. Schachar, R., & Tannock, R. (1995). Test of four hypotheses for the comorbidity of attention-deficit hyperactivity disorder and conduct disorder. Journal of American Academy of Child and Adolescent Psychiatry, 34, 639-648.
184. Schepis, S., Adinoff, B., & Rao, U. (2008). Neurobiological processes in adolescent addictive disorders. American Journal of Addictions, 17(1), 6-23.
185. Schubiner, H., Saules, K. K., Arfken, C. L., Johanson, C. E., Schuster, C. R., Lockhart, N.,... Pihlgren, E. (2002). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology, 10, 286-294.
186. Schubiner, H., Tzelepis, A., Milberger, S., Lockhart, N., Kruger, M., Kelley, B. J., & Schoener, E. P. (2000). Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry, 61, 244-251.
187. Schwebel, R. (2004). The Seven Challenges manual. Tucson, AZ: Viva.
188. Scott, W. C., Kaiser, D., Othmer, S., & Sideroff, S. I. (2005). Effects of an EEG biofeedback protocol on a mixed substance abusing population. American Journal of Drug Alcohol Abuse, 31, 455-469.
189. Shaw, P., Lerch, J., Greenstein, D., Sharp, W., Clasen, L., Evans, A.,... Rapoport, J. (2006). Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 63, 540-549.
190. Sherlin, L., Arns, M., Lubar, J., & Sokhadze, E. (2010). A position paper on neurofeedback for the treatment of ADHD. Journal of Neurotherapy, 14(2), 66-78.
191. Silberstein, R. B., Farrow, M., Levy, F., Pipingas, A., Hay, D. A., & Jarman, F. C. (1998). Functional brain electrical activity mapping in boys with attention-deficit/ hyperactivity disorder. Archives of General Psychiatry, 55, 1105-1112.
192. Simkin, D. R. (2002). Adolescent substance use disorders and comorbidity. Pediatric Clinics of North America, 49, 463-477.
193. Sokhadze, E. M. (2005). Neurofeedback and cognitive-behavioral therapy based intervention in dual diagnosis: A neurobiological model. Journal of Neurotherapy, 9, 123-124.
194. Sokhadze, E., Cowan, J., Tasman, A., Sokhadze, G., Horrell, T., & Stewart, C. (2010, September 30). Effects of gamma neurofeedback training on perceived positive emotional state and cognitive functions. Paper presented at the ISNR meeting, Denver, CO.
195. Sokhadze, E. M., & Shtark, M. B. (1991). Scientific and clinical biofeedback in USSR. Biofeedback & Self-Regulation, 16, 253-260.
196. Sokhadze, E., Stewart, C., & Hollifield, M. (2007). Integrating cognitive neuroscience methods with neurofeedback therapy in treatment of substance use disorder comorbid with PTSD. Journal of Neurotherapy, 11(2), 13-44.
197. Sokhadze, E., Stewart, C., Hollifield, M., & Tasman, A. (2008). Event-related study of executive dysfunctions in a speeded reaction task in cocaine addiction. Journal of Neurotherapy, 12, 185-204.
198. Sokhadze, E., Stewart, C., Sokhadze, G., Husk, M., & Tasman, A. (2009). Effects of neurofeedback-based behavioral therapy on ERP measures of executive functions in drug abuse. Journal of Neurotherapy, 13, 260-262.
199. Sokhadze, G., Sears, L., & Sokhadze, E. (2010, September 30). Neurofeedback training to improve attention and control alertness in ADHD. Paper presented at the ISNR meeting, Denver, CO.
200. Sokhadze, T. M., Cannon, R., & Trudeau, D. L. (2008). EEG biofeedback as a treatment for substance use disorders: Review, rating of efficacy and recommendations for future research. Applied Psychophysiology & Biofeedback, 33, 1-28.
201. Somoza, E. C., Winhusen, T. M., Bridge, T. P., Rotrosen, J. P., Vanderburg, D. G., Harrer, J. M.,... Barrett, J. A. (2004). An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addictive Diseases, 23(1), 77-92.
202. Steinberg, L. (2007). Risk taking in adolescence. New perspectives from brain and behavioral science. Current Directions in Psychological Science, 16(2), 55-59.
203. Stevens, S., & Ruiz, B. (2006, March 28). Outcome findings of adolescents enrolled in The Seven Challenges outpatient and alternative school programs. Paper presented at the Joint Meeting of Adolescent Treatment Effectiveness, Baltimore, MD.
204. Stevens, S. J., Schwebel, R., & Ruiz, B. (2007). The Seven Challenges: An effective treatment for adolescents with co-occurring substance abuse and mental health problems. Journal of Social Work Practice in the Addictions, 7(3), 29-49.
205. Strandburg, R. J., Marsh, J. T., Brown, W. S., Asarnow, R. F., Higa, J., Harper R., & Guthrie, D. (1996). Continuous-processingrelated event-related potentials in children with attention deficit hyperactivity disorder. Biological Psychiatry, 40, 964-980.
206. Struve, F. A., Straumanis, J. J., & Patric, G. (1994). Persistent topographic quantitative EEG sequelae of chronic marijuana use: A replication study and initial discriminant function analysis. Clinical Electroencephalography, 25, 63-75.
207. Struve, F. A., Straumanis, J. J., Patric, G., & Price, L. (1989). Topographic mapping of quantitative EEG variables in chronic heavy marijuana users: Empirical findings with psychiatric patients. Clinical Electroencephalography, 20(1), 6-23.
208. Substance Abuse and Mental Health Services Administration. (2007). Results from the 2006 National Survey on Drug Use and Health: National findings (Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293). Rockville, MD: Author.
209. Sussman, S. (2010). A review of alcoholics anonymous/narcotic anonymous programs for teens. Evaluation & Health Professions, 33(1), 26-55.
210. Swadi, H. (1999). Individual risk factors for adolescent substance use. Drug and Alcohol Dependence, 55, 209-224.
211. Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G., Volkow, N.,... Wadhwa, P. D. (2007). Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology Reviews, 17(1), 39-59.
212. Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K., Abikoff, H. B., et al. (2001). Clinical relevance of the primary findings of the MTA: Success rate based on severity of ADHD and ODD symptoms at the end of treatment. Journal of American Academy of Child and Adolescent Psychiatry, 40, 168-179.
213. Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J., Jensen, P. S., & Cantwell, D. P. (1998). Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet, 351, 429-433.
214. Swartz, J. A., & Lurigio, A. J. (1999). Psychiatric illness and comorbidity among adult male jail detainees in drug treatment. Psychiatry Service, 50, 1628-1630.
215. Tarter, R. E., Kirisci, L., Habeych, M., Reynolds, M., & Vanyukov, M. M. (2004). Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood. Direct and mediated tiologic pathways. Drug Alcohol Dependence, 73, 121-132.
216. Tarter, R. E., Kirisci, L., Mezzich, A., Cornelius, J., Pajer, K., Vanyukov, M. M.,... Clark, D. (2003). Neurobehavior disinhibition in childhood predicts early age at onset of substance disorder. American Journal of Psychiatry, 160, 1078-1085.
217. Trudeau, D. L. (2000a). Individualizing EEG biofeedback in addictive disorders. Biofeedback, 28(3), 22-26.
218. Trudeau, D. L. (2000b). A review of the treatment of addictive disorders by EEG biofeedback. Clinical Electroencephalography, 31, 13-26.
219. Trudeau, D. L. (2005a). Applicability of brain wave biofeedback to substance use disorder in adolescents. Child and Adolescent Clinics of North America, 14, 125-136.
220. Trudeau, D. L. (2005b). EEG biofeedback for addictive disorders-The state of the art in 2004. Journal of Adult Development, 12, 139-146.
221. Trudeau, D. L., Sokhadze, T. M., & Cannon, R. (2008). Neurofeedback in alcohol and drug dependency. In T. Budzynski, J. Evans & H. Budzynski (Eds.), Advanced QEEG and neurofeedback (pp. 239-267). Amsterdam, the Netherlands: Elsevier.
222. Trudeau, D. L., Thuras, P., & Stockley, H. (1999). Quantitative EEG findings associated with chronic stimulant and cannabis abuse and ADHD in an adult male substance use disorder population. Clinical Electroencephalography, 30, 165-174.
223. Van den Bergh, W. (2010). Neurofeedback and state regulation in ADHD: A therapy without medication (S. Clark, English trans.). Corpus Christi, TX: BMED Press.
224. Van den Brink, W., & van Ree, J. M. (2003). Pharmacological treatments for heroin and cocaine addictions. European Neuropsychopharmacology, 13, 476-487.
225. Van Meel, C. S., Heslenfeld, D. J., Oosterlaan, J., & Sergeant, J. A. (2007). Adaptive control deficits in attention-deficit/hyperactivity disorder (ADHD): The role of error processing. Psychiatry Research, 151, 211-220.
226. Volkow, N. D., & Fowler, J. S. (2000). Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex, 10, 318-325.
227. Volkow, N. D., Fowler, J. S., & Wang, G. J. (2003). The addicted human brain: Insights from imaging studies. Journal of Clinical Investigations, 111, 1444-1451.
228. Volkow, N. D., Fowler, J. S., & Wang, G. J. (2004). The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology, 47, 3-13.
229. Wexler, B. E., Gottschalk, C. H., Fulbright, R. K., Prohovnik, I., Lacadie, C. M., Rounsaville, B. J., & Gore, J. C. (2001). Functional Magnetic Resonance Imaging of cocaine craving. American Journal of Psychiatry, 158, 86-95.
230. Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R.,... Fusillo, S. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry, 47(1), 21-31.
231. Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L., Moore, R. J.,... Levine, L. R. (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug & Alcohol Dependence, 96(1-2), 145-154.
232. Wilens, T. E., Biederman, J., & Mick, E. (1998). Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. American Journal of Addictions, 7, 156-163.
233. Williams, J. M. (2010). Does neurofeedback help reduce attention-deficit hyperactivity disorder? Journal of Neurotherapy, 14, 261-279.
234. Williams, L. M. (2006). An integrative neuroscience model of "significance" processing. Journal of Integrative Neuroscience, 5, 1-47.
235. Williams, L. M., Hermens, D. F., Palmer, D., Kohn, M., Clarke, S., Keage, H.,... Gordon, E. (2008). Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: Evidence for a neural marker and stimulant effects. Biological Psychiatry, 63, 917-926.
236. Winterer, G., Smolka, M., Samochowiec, J., Ziller, M., Mahlberg, R., Gallinat, J.,... Sander, T. (2003). Association of EEG coherence and an exonic GABABR1 gene polymorphism. American Journal of Medical Genetics, 117B, 51-56.
237. World Health Organization. (1992). International statistical classification of disease and related health problems (10th rev.). Geneva, Switzerland: Author.
238. Yordanova, J., Banaschewski, T., Kolev, V., Woerner, W., & Rothenberger, A. (2001). Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder-Evidence from event-related gamma oscillations. Clinical Neurophysiology, 112, 1096-1108.